WAYNE CHEN: Open Payments
NPI 1679640841 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 73 payments from 17 companies in 2025. Trend: 2023 $762 · 2024 $1,064 · 2025 $1,764
Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $208 |
| Madrigal Pharmaceuticals | 5 | $190 |
| Janssen Biotech, Inc. | 10 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $177 |
| Aimmune Therapeutics, Inc. | 5 | $150 |
| Ardelyx, Inc. | 7 | $141 |
| QOL Medical, LLC | 3 | $121 |
| Lilly USA, LLC | 6 | $118 |
| Exact Sciences Corporation | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
Products named: XIFAXAN, REZDIFFRA, TREMFYA, ZENPEP, IBSRELA, Sucraid, ENTYVIO, OMVOH.
Industry payments across CT — which companies pay providers there.
